- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01504048
Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis
Prospective Study on the Usefulness of Chromoendoscopy in Detecting Microscopic Colitis in Patients Undergoing Colonoscopy Due to Chronic Watery Diarrhoea
Study Overview
Status
Intervention / Treatment
Detailed Description
Microscopic colitis is a common disease found in 10% to 20% of cases having chronic watery diarrhea. Obvious endoscopically identifiable changes of the mucosal surface are usually absent, thus diagnosing microscopic colitis relies on multiple biopsy sampling from all segments of the colon. Chromoendoscopy using indigo-carmine dye spray might, however, unravel mucosal changes in microscopic colitis (Suzuki 2011).
The aim of this study is to investigate if chromoendoscopy using Indigo-Carmine 0.2-0.5% in patients with chronic watery diarrhea is useful in diagnosing microscopic colitis.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Peter T Schmidt, MD, PhD
- Phone Number: +46 8 51770000
- Email: peter.thelin.schmidt@ki.se
Study Locations
-
-
-
Stockholm, Sweden, 17176
- Recruiting
- Karoliniska University Hospital, Dept. of Gastroenterology
-
Contact:
- Peter T Schmidt, MD, PhD
- Phone Number: +46 8 51770000
- Email: peter.thelin.schmidt@ki.se
-
Principal Investigator:
- Peter T Schmidt, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with chronic non-bloody diarrhea for at least one month
Exclusion Criteria:
- Patients who decline to participate
- Unable to give informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Chromoendoscopy
|
Colonoscopy with chromoendoscopy using 0.2-0.5% Indigo-Carmine solution sprayed in five areas of the large intestine: Cecum, ascending colon, transverse colon, descending colon and rectum.
Pictures are taken before and after dye-spraying and biopsies are collected from all segments of the large intestine and rectum.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Detection of microscopic colitis using chromoendoscopy
Time Frame: 12 month
|
To investigate the usefullness of chromoendoscopy in diagnosing microscopic colitis using 0.2-0.5% Indigo-Carmine dye spray.
The golden standard is the results of histological examination of biopsies from the colo-rectal mucosa.
|
12 month
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PTS-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lymphocytic Colitis
-
Dr. Falk Pharma GmbHCompleted
-
Technische Universität DresdenDr. Falk Pharma GmbHCompleted
-
Maastricht University Medical CenterCompletedLymphocytic Colitis | Microscopic Colitis | Collagenous ColitisNetherlands
-
Mayo ClinicAstraZeneca; National Center for Research Resources (NCRR)TerminatedDiarrhea | Lymphocytic ColitisUnited States
-
ViomeTerminatedObesity | Gastritis | Irritable Bowel Syndrome | Gastric Cancer | Esophageal Cancer | Gastro Esophageal Reflux | Crohn Disease | GERD | NAFLD | Ulcerative Colitis | Eosinophilic Esophagitis | Gastric Ulcer | Duodenal Ulcer | Barrett Esophagus | Intestinal Metaplasia | Colon Polyp | Lymphocytic Colitis | IBS | SIBO | Gallstone Disease | Microscopic Colitis and other conditionsUnited States
-
Dr. Falk Pharma GmbHThe Swedish Organization for Studies on Inflammatory Bowel DiseaseCompletedInduction and Maintaining Remission of Collagenous ColitisGermany, Sweden
-
Dr. Falk Pharma GmbHCompletedIncomplete Microscopic ColitisGermany, Sweden
-
Dr. Falk Pharma GmbHCompletedCollagenous ColitisGermany
-
Technische Universität DresdenAstraZenecaCompleted
-
Bonderup, Ole K., M.D.UnknownCollagenous Colitis
Clinical Trials on Colonoscopy with Indigo-Carmine Chromoendoscopy
-
Karolinska University HospitalUnknownUlcerative Colitis | Crohn's ColitisSweden
-
Mayo ClinicCompletedColonic PolypsUnited States
-
Hospital Universitario de MóstolesCompletedColonic Polyp | Colonic Neoplasms | Colonic Cancer
-
King's College Hospital NHS TrustCompletedInflammatory Bowel DiseaseUnited Kingdom
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedUlcerative Colitis | ChromoendoscopyNetherlands
-
Weill Medical College of Cornell UniversityCompletedBrain Tumors With Ill-defined MarginsUnited States
-
Walter BrunnerCompletedRectal NeoplasmsSwitzerland
-
The Leeds Teaching Hospitals NHS TrustUnknown
-
Hospices Civils de LyonUnknownAdenoma Detection to Prevent Colorectal CancerFrance
-
VA Office of Research and DevelopmentCompletedColorectal NeoplasmsUnited States